1xbet 한국 Pharmaceutical Co., Ltd.

1xbet 한국 Pharmaceutical Co., Ltd. will market POConePlus_®1xbet 한국frared Spectrophotometer for diagnosis ofH. pylori (Helicobacter pylori) to medical 1xbet 한국stitutions across Japan from December 13, 2019.

This device is an 1xbet 한국frared spectrophotometer that measures the change 1xbet 한국 the isotope ratio of carbon dioxide (¹³CO₂ / ¹²CO₂) conta1xbet 한국ed 1xbet 한국 exhaled breath, to be used with a diagnostic drug component (¹³C- urea) to confirm the presence or absence ofH. pylori.

As a successor to POCone_®that 1xbet 한국 Pharmaceutical has been marketing since 2004, it features improved operability and readability by incorporating the needs of medical institutions, and colorization of the touch-panel and display. In addition, a further-enhanced device, POConePlus-AS10_®, which can assess up to 10 patients, will be marketed.